Search Tag: Hepatitis C

Lab Management

Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA & HIV-1 Assays on DxN VERIS MDS

2015 10 Jun

—Beckman Coulter Diagnostics has obtained CE Marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV- 1)... Read more

Executive Health Management

Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays

2015 21 Apr

HERCULES, CA and BREA, CA--(Marketwired - Apr 20, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products and Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, today announced that Bio-Rad is extending its agreement with Beckman Coulter... Read more

ICU Management

Combo Therapy Eradicates Hep C in Liver Transplant Patients

2014 10 Nov

Researchers from the Mayo Clinic (Jacksonville, FA, USA) have found that the use of two new oral medications is effective in fighting hepatitis C infection amongst liver transplant patients. Given the clinical importance of the study, results have been presented in a plenary session of the American Association for the Study of Liver Diseases (The Liver... Read more

Pharmacy Management

First Combination Pill Approved For Hepatitis C

2014 14 Oct

The FDA has approved a new antiviral drug to treat chronic hepatitis C virus (HCV) genotype 1 infections. Harvoni from Gilead Sciences is the first combination drug (ledipasvir/sofosbuvir) for the treatment of HCV as well as the first treatment for the disease that does not require administration with interferon and ribavirin. Edward Cox, MD, MPH,... Read more


Endorsed Companies